PRMT5 and ovarian carcinoma: To explore the clinical relevance of our findings, we performed immunohistochemistry (IHC) staining to determine the PRMT5 protein levels in clinical sample tissues of ovarian cancer (Cohort 1: ovarian cancer tissues [T, n = 39], normal tissues [N, n = 22]).